Change in vital parameters at first methylphenidate administration as a predictor of treatment response at six-month follow-up
Methylphenidate is the primary pharmacological treatment for attention-deficit/hyperactivity disorder (ADHD), yet approximately 30% of patients show a poor clinical response. Currently, no reliable biomarkers exist to predict which patients will…
Suggested reading